Last reviewed · How we verify
Sativex
Sativex is a Small molecule drug developed by Jazz Pharmaceuticals. It is currently FDA-approved for Muscle Spasticity due to Multiple Sclerosis. Also known as: Nabiximols, GW1000-02, THC/CBD spray, GW-1000-02.
Sativex, also known as nabiximols, is a botanical drug approved in the UK in 2010 as a mouth spray for the treatment of multiple sclerosis symptoms, including neuropathic pain, spasticity, and overactive bladder. It is a small molecule modality that contains a cannabis extract, specifically a THC-dominant cannabis formulation.
At a glance
| Generic name | Sativex |
|---|---|
| Also known as | Nabiximols, GW1000-02, THC/CBD spray, GW-1000-02, THC:CBD spray |
| Sponsor | Jazz Pharmaceuticals |
| Modality | Small molecule |
| Therapeutic area | Neuroscience |
| Phase | FDA-approved |
Approved indications
- Muscle Spasticity due to Multiple Sclerosis
Common side effects
Key clinical trials
- EFFECTS OF A FULL SPECTRUM CANNABIS EXTRACT WITH DIFFERENT DOSES OF CBD AND THC ON THE MODULATION OF FIBROMYALGIA: A PILOT, MULTICENTER, OPEN LABEL CLINICAL TRIAL (FRIDINHA) (PHASE1, PHASE2)
- Repetitive Transcranial Magnetic Stimulation for Cannabis Use Disorder (NA)
- Perceptions of Proposed Warnings for Cannabis Edibles Packaging (NA)
- Study of Language Disorders and Interactions Between Mnesic Capabilities and Semantic Competencies in Patients With Psychosis (NA)
- Preventing Impaired Driving Among Adolescents (NA)
- Neuroimaging of Adolescent Cannabis Use Treatment (NA)
- Prospective Evaluation on Cognitive Function and Its Associated Genetic Vulnerability in Cannabis Users
- Feasibility and Acceptability Trial to Reduce Tobacco and Cannabis Use During Pregnancy and Postpartum (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sativex CI brief — competitive landscape report
- Sativex updates RSS · CI watch RSS
- Jazz Pharmaceuticals portfolio CI
Frequently asked questions about Sativex
What is Sativex?
What is Sativex used for?
Who makes Sativex?
Is Sativex also known as anything else?
What development phase is Sativex in?
Related
- Manufacturer: Jazz Pharmaceuticals — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Indication: Drugs for Muscle Spasticity due to Multiple Sclerosis
- Also known as: Nabiximols, GW1000-02, THC/CBD spray, GW-1000-02, THC:CBD spray
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing